Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Thomas M. Turner Jr.

Market Cap

20.24 Million USD

Sector

Healthcare

Website

https://www.cordovacann.com

Description

CordovaCann Corp., a cannabis-focused consumer products company, primarily provides services and investment capital to the processing, production, and retail vertical markets of the cannabis industry.

Read More

Overview

Value

3

Growth

12

Health

34

Management

59

Analyst Opinion

0

Total

27

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • Does not hold enough liquid assets to cover short term liabilities
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth
  • Accounting anomalies: Growing revenues without a corresponding growth in cash flows.
  • 0

Market Peers

LVRLF

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-77.46%

Revenue Growth (5 Year Average)

9.29%

Ratings Consensus

N/A

Share Buybacks

-7.76%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

3

  • Estimated intrinsic-value of 42.83 undefined USD is lower than current price ( 184.80 undefined USD)
  • Free-cashflow-yeild of -3.31% is worse than the market average (4.7%)
  • Margin-of-safety of -77.46% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 0.1 USD

Current Price: 0.2 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-3.31%

PE/Earnings Growth

N/A

Price/Book

2.76x

Growth

Growth Score

12

  • Earnings growth has improved this year
  • Free Cashflow growth has improved this year
  • 5 Year Average Revenue growth of 9.29% is lower than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of -16.44% is lower than the market average (14.48%)
  • 5 Year Average Free Cashflow growth of -1.88% is lower than the market average (12.35%)

Revenue Growth

9.29%

Earnings Growth

-16.44%

Cashflow Growth

-1.88%

Health

Health Score

34

  • Cashflow is negative
  • Has a high level of debt
  • Assets do not cover liabilities
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

0.93x

Current Assets/Liabilities

0.19x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

4.73x

Management

Management Score

59

  • Has issued new shares to finance growth when share price is high
  • Return-on-capital-employed of 0.19% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of -10.35% is lower than the market average (15%)

Average Buybacks/Dilution

-7.76%

Recent Buybacks/Dilution

30.40%

5 Year Price Volitility

90.52%

Return On Assets

-3.71%

Return On Capital Employed

0.19%

Return On Equity

-10.35%

Return On Free Cashflow

294.54%

Return On Investments

N/A

Analysts

Analyst Opinion

0

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    Other Information

    Company Name

    CordovaCann Corp.

    Currency

    USD

    Beta

    0.833275

    Vol Avg

    38318

    Ceo

    Mr. Thomas M. Turner Jr.

    Cik

    0001168981

    Cusip

    21864T107

    Exchange

    Other OTC

    Full Time Employees

    Industry

    Drug Manufacturers—Specialty & Generic

    Sector

    Healthcare

    Ipo Date

    2007-06-19

    Address

    217 Queen Street West

    City

    Toronto

    State

    ON

    Country

    CA

    Zip

    M5V 0R2

    Phone

    All financial data provided by FMP

    Noticed an error with something on our site?

    We Use Cookies